Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TN/Murfreesboro
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Murfreesboro, TN

Studies commonly pay $75 to $4,500 per completed study

79 clinical trials are currently recruiting participants within 30 miles of Murfreesboro. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

79studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Murfreesboro right now

Top 25 of 79 recruiting studies, sorted by proximity — each links to its official registry page

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer Phase 3 Interventional 1,000 participants sought
Tennessee Oncology, PLLC - Murfreesboro — Murfreesboro, Tennessee (1.2 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07028853)

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Psoriasis, Overweight or Obesity Phase 4 Interventional 200 participants sought
DelRicht Research - Thompson's Station — Smyrna, Tennessee (11.0 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06857942)

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Urothelial Cancer, Advanced/Metastatic Urothelial Cancer Phase 1, Phase 2 Interventional 132 participants sought
Tennessee Oncology, PLLC - Murfreesboro — Murfreesboro, Tennessee (1.2 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07421700)

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer (CRC) Phase 3 Interventional 600 participants sought
Clinical Study Site — Hermitage, Tennessee (26.7 mi) · Sponsor: Summit Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT07228832)

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

Schizophrenia N/A Observational 1,500 participants sought
Psychiatric Consultants, Pc — Franklin, Tennessee (26.1 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07379827)

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic Phase 3 Interventional 680 participants sought
Tennessee Oncology, PLLC - Murfreesboro — Murfreesboro, Tennessee (1.2 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07144280)

Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

Alzheimer Disease, Dementia N/A Interventional 456 participants sought
National HealthCare Corporation — Murfreesboro, Tennessee (1.2 mi) · Sponsor: University of Alabama, Tuscaloosa
See eligibility & contact on ClinicalTrials.gov (NCT05820919)

A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

Radiographic Axial Spondyloarthritis Phase 2 Interventional 315 participants sought
AARA Clinical Research - Murfreesboro Medical Clinic ( Site 0029) — Murfreesboro, Tennessee (1.2 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT07133633)

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma Phase 1, Phase 2 Interventional 224 participants sought
Tennessee Oncology, PLLC-Murfreesboro — Murfreesboro, Tennessee (1.2 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07227415)

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Moderate to Severe Chronic Obstructive Pulmonary Disease Phase 2, Phase 3 Interventional 1,156 participants sought
Clinical Trials Center of Middle Tennessee, LLC — Franklin, Tennessee (26.1 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07363694)

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

Alopecia Areata Phase 3 Interventional 355 participants sought
Delricht Research - Smyrna — Smyrna, Tennessee (11.0 mi) · Sponsor: Sun Pharmaceutical Industries, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07133308)

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis Phase 3 Interventional 2,150 participants sought
Akero Clinical Study Site — Hermitage, Tennessee (26.7 mi) · Sponsor: Akero Therapeutics, Inc
See eligibility & contact on ClinicalTrials.gov (NCT06528314)

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis Phase 3 Interventional 762 participants sought
89bio Clinical Study Site — Hermitage, Tennessee (26.7 mi) · Sponsor: 89bio, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06419374)

A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa (HS) Phase 2, Phase 3 Interventional 210 participants sought
DelRicht Research — Smyrna, Tennessee (11.0 mi) · Sponsor: Bluefin Biomedicine, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07287644)

A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

Non-cystic Fibrosis Bronchiectasis Phase 2 Interventional 284 participants sought
Clinical Trials Center of Middle Tennessee — Franklin, Tennessee (26.1 mi) · Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
See eligibility & contact on ClinicalTrials.gov (NCT06559150)

A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

Psoriatic Arthritis, Overweight or Obesity Phase 4 Interventional 200 participants sought
AARA Clinical Research - Murfreesboro Medical Clinic — Murfreesboro, Tennessee (1.2 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06864026)

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Major Depressive Disorder Phase 2 Interventional 164 participants sought
Psychiatric Consultants, PC — Franklin, Tennessee (26.1 mi) · Sponsor: Syndeio Biosciences, Inc
See eligibility & contact on ClinicalTrials.gov (NCT07115329)

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Generalized Anxiety Disorder (GAD) Phase 2 Interventional 315 participants sought
Psychiatric Consultants - Franklin /ID# 275133 — Franklin, Tennessee (26.1 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06846320)

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus Phase 3 Interventional 450 participants sought
Sl0044 50693 — Murfreesboro, Tennessee (1.2 mi) · Sponsor: UCB Biopharma SRL
See eligibility & contact on ClinicalTrials.gov (NCT06617325)

A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

Idiopathic Pulmonary Fibrosis Phase 2 Interventional 71 participants sought
Clinical Trials Center of Middle Tennessee, LLC — Franklin, Tennessee (26.1 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07036523)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
Vanderbilt-Ingram Cancer Center Cool Springs — Franklin, Tennessee (26.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07198074)

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

Psychosis Associated With Alzheimer's Disease Phase 3 Interventional 410 participants sought
Local Institution - 1038 — Franklin, Tennessee (26.1 mi) · Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See eligibility & contact on ClinicalTrials.gov (NCT05511363)
Actively enrolling

Studies you may be able to join near Murfreesboro

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Murfreesboro

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

International Clinical Research-Tennessee, LLC

★ 3.9
1035 N Highland Ave, Murfreesboro, TN 37130
(615) 410-3460
"I participated in an IC Research clinical study for a full year, and I can’t recommend them to anyone. On three separate occasions they failed to dis…"
— Hamid Ashari, 1★

Comprehensive Cancer Center

1840 Medical Center Pkwy, Murfreesboro, TN 37129
(615) 396-5530

MMC — Internal and Family Medicine

★ 4.9
1272 Garrison Dr, Murfreesboro, TN 37129
(615) 867-8010
"Very friendly staff they help you with any questions you may have."
— George R. Mcclain, 4★

Trustpoint Hospital

★ 2.7 (448 reviews)
1009 N Thompson Ln, Murfreesboro, TN 37129
(615) 716-1824
"So ghetto unprofessional don’t return phone calls lady that answered the phone this morning was very unprofessional believe what these reviews say th…"
— Twaina Woods, 1★

DelRicht Research of Thompson's Station Clinical Trials

★ 5.0
521 Stonecrest Pkwy #201, Smyrna, TN 37167
(504) 336-2667
"I absolutely would recommend them. Constance has made a magnificent impact on my short time here. All the nurses and Doctors been knowledgeable about…"
— Jaycie Oldham, 5★

Clinical Trials Center of Middle Tennessee

★ 5.0
100 Covey Dr, Franklin, TN 37067
(615) 205-8350
"We have been coming for over a year, and it has been a life changing experience, everyone is so friendly and helpful and easy to work with."
— Aggie Campbell, 5★

Clinical Research Solutions - Smyrna, TN

515 Stonecrest Pkwy #110, Smyrna, TN 37167
(615) 984-3365

HCCA Clinical Research

515 Stonecrest Pkwy, Smyrna, TN 37167
(615) 462-6346

Southeast Clinical Research

★ 5.0
224 Took Dr, Antioch, TN 37013
(615) 739-6512

Clinical trials in Murfreesboro: what's recruiting

The Murfreesboro area currently has 79 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Murfreesboro, the most active research areas are:

  • Cancer & Oncology7 studies
  • Diabetes & Metabolism5 studies
  • Brain & Mental Health5 studies
  • Immune & Skin4 studies
  • Liver & Kidney3 studies

Every listing shows the study phase, the recruiting site and its distance from Murfreesboro, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Murfreesboro

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Murfreesboro participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Murfreesboro pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Murfreesboro?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Murfreesboro?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Murfreesboro.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Murfreesboro typically complete one or two studies per year.

Paid clinical trials near Murfreesboro

Other metros within reach

Nashville, TN1,347 Huntsville, AL89 Clarksville, TN9 Chattanooga, TN150 Birmingham, AL962 Evansville, IN68 Louisville, KY574 Knoxville, TN228

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Murfreesboro Bladder Issues Due To Spinal Cord Injury in Murfreesboro All conditions

More of TN

Nashville1,347 Memphis584 Knoxville228 Chattanooga150 Clarksville9

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts